Yan X, Qu X, Wang J, Lu L, Wu W, Mao J
MedComm (2020). 2025; 6(3):e70137.
PMID: 40066228
PMC: 11892016.
DOI: 10.1002/mco2.70137.
Kalies K, Knopp K, Koch S, Pilowski C, Wurmbrand L, Sedding D
PLoS One. 2025; 20(2):e0319381.
PMID: 40019880
PMC: 11870368.
DOI: 10.1371/journal.pone.0319381.
Li Z, Guo S, Cao K, Duan Y, Zhao Y, Zhang Y
MedComm (2020). 2025; 6(2):e70089.
PMID: 39949978
PMC: 11822463.
DOI: 10.1002/mco2.70089.
Yakovenko I, Mihai I, Selinger M, Rosenbaum W, Dernstedt A, Groning R
Nucleic Acids Res. 2025; 53(3).
PMID: 39878215
PMC: 11775621.
DOI: 10.1093/nar/gkaf031.
Hou C, Xu J, Zhou M, Huo J, Wang X, Jiang W
Biochem Biophys Rep. 2025; 41:101911.
PMID: 39877037
PMC: 11773089.
DOI: 10.1016/j.bbrep.2024.101911.
Rewiring cancer: 3D genome determinants of cancer hallmarks.
Amodeo M, Eyler C, Johnstone S
Curr Opin Genet Dev. 2025; 91:102307.
PMID: 39862605
PMC: 11867856.
DOI: 10.1016/j.gde.2024.102307.
RNF112, whose transcription is regulated by KLF4, inhibits colorectal cancer growth via promoting ubiquitin-dependent degradation of NAA40.
Li C, Guan W, Geng D, Feng Y
Cell Biol Toxicol. 2025; 41(1):22.
PMID: 39757327
PMC: 11700914.
DOI: 10.1007/s10565-024-09977-z.
Comprehensive analysis of telomere and aging-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
Ye Z, Huang Y, Chen T, Wu Y
J Cardiothorac Surg. 2025; 20(1):31.
PMID: 39757226
PMC: 11702222.
DOI: 10.1186/s13019-024-03337-y.
KLF4 promotes cisplatin resistance by activating mTORC1 signaling in ovarian cancer.
Zhou W, Huang H, Teng Y, Hua R, Hu Y, Li X
Discov Oncol. 2024; 15(1):682.
PMID: 39565445
PMC: 11579265.
DOI: 10.1007/s12672-024-01576-y.
A Sendai virus-based expression system directs efficient induction of chondrocytes by transcription factor-mediated reprogramming.
Zhou J, Sekiguchi Y, Sano M, Nishimura K, Hisatake K, Fukuda A
Sci Rep. 2024; 14(1):26004.
PMID: 39472618
PMC: 11522313.
DOI: 10.1038/s41598-024-77508-1.
KLF4 regulates trophoblast function and associates with unexplained recurrent spontaneous abortion.
Tan Y, Wang J, Liu C, Wu S, Zhou M, Zhang Y
J Transl Med. 2024; 22(1):922.
PMID: 39390495
PMC: 11465507.
DOI: 10.1186/s12967-024-05707-5.
Bioengineered Anthocyanin-Enriched Tomatoes: A Novel Approach to Colorectal Cancer Prevention.
Suzauddula M, Kobayashi K, Park S, Sun X, Wang W
Foods. 2024; 13(18).
PMID: 39335919
PMC: 11430996.
DOI: 10.3390/foods13182991.
Inhalation Anesthetics Play a Janus-Faced Role in Self-Renewal and Differentiation of Stem Cells.
Hao X, Li Y, Gao H, Wang Z, Fang B
Biomolecules. 2024; 14(9).
PMID: 39334933
PMC: 11430341.
DOI: 10.3390/biom14091167.
PDCD10 Is a Key Player in TMZ-Resistance and Tumor Cell Regrowth: Insights into Its Underlying Mechanism in Glioblastoma Cells.
Zhu Y, Kim S, Chen Z, Will R, Zhong R, Dammann P
Cells. 2024; 13(17.
PMID: 39273014
PMC: 11394141.
DOI: 10.3390/cells13171442.
Versatile Split-and-Mix Liposome PROTAC Platform for Efficient Degradation of Target Protein .
Song C, Jiao Z, Hou Z, Xing Y, Sha X, Wang Y
JACS Au. 2024; 4(8):2915-2924.
PMID: 39211615
PMC: 11350581.
DOI: 10.1021/jacsau.4c00278.
Puerarin attenuates myocardial ischemic injury and endoplasmic reticulum stress by upregulating the Mzb1 signal pathway.
Xue J, Ren H, Zhang Q, Gu J, Xu Q, Sun J
Front Pharmacol. 2024; 15:1442831.
PMID: 39206261
PMC: 11350615.
DOI: 10.3389/fphar.2024.1442831.
Single-cell landscape revealed immune characteristics associated with disease phases in brucellosis patients.
Wang Y, Yang S, Han B, Du X, Sun H, Du Y
Imeta. 2024; 3(4):e226.
PMID: 39135683
PMC: 11316929.
DOI: 10.1002/imt2.226.
GABRP inhibits the progression of oesophageal cancer by regulating CFTR: Integrating bioinformatics analysis and experimental validation.
Zhang J, Liu X, Zeng L, Hu Y
Int J Exp Pathol. 2024; 105(4):118-132.
PMID: 38989629
PMC: 11263814.
DOI: 10.1111/iep.12513.
Optimized rAAV8 targeting acinar KLF4 ameliorates fibrosis in chronic pancreatitis via exosomes-enriched let-7s suppressing pancreatic stellate cells activation.
Zhao Y, Feng Y, Sun F, Li L, Chen J, Song Y
Mol Ther. 2024; 32(8):2624-2640.
PMID: 38956871
PMC: 11405174.
DOI: 10.1016/j.ymthe.2024.06.030.
CRISPR-Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer.
Smith D, Lunj S, Adamson A, Nagarajan S, Smith T, Reeves K
Nat Rev Urol. 2024; 22(1):55-65.
PMID: 38951705
DOI: 10.1038/s41585-024-00901-y.